Foreign traditional Chinese medicine is sold back to China in a large scale, and the backward planting mode endangers the quality of traditional Chinese Medicine

Due to the dispersion of agriculture, backward management and low quality of farmers in China, some farmers use illegal pesticides in the process of planting traditional Chinese medicine, and the country has not yet developed a perfect quality standard of traditional Chinese medicine, which leads to frequent incidents of pesticide residues and heavy metals in traditional Chinese medicine At present, the market share of foreign traditional Chinese medicine in China has reached 1 / 3, which directly threatens the healthy development of China's traditional Chinese medicine industry Industry insiders believe that China should establish a comprehensive evaluation system for the quality of traditional Chinese medicine in line with the theory of traditional Chinese medicine as soon as possible, and establish a special organization to guide farmers to use pesticides and fertilizers reasonably At the same time, enterprises should increase investment in science and technology, improve the quality of traditional Chinese medicine products, and speed up the industrialization and internationalization of traditional Chinese medicine There is a dispute about the backward detection standard of planting technology in Anguo City, Hebei Province The planting area of traditional Chinese medicine is more than 70000 mu, and there are more than 40 varieties The main varieties are "eight Qiyao" in addition to job's tears price As one of the distribution centers of Chinese herbal medicines in China, Anguo operates nearly 2000 kinds of Chinese herbal medicines Most of the Chinese herbal medicines in the country can be purchased in Anguo Chinese herbal medicine market It is understood that there are many sources of goods in Anguo's specialized market of traditional Chinese medicine from planting retail investors, and the scattered individual planting has brought some difficulties to the supervision Due to the lack of guidance, the cultivation and pest control technologies of retail farmers are generally backward, and they need to rely more on chemical fertilizers and pesticides Huo Zhijun, the head of the professional cooperative of traditional Chinese medicine science and technology planting in huozhuang village, Anguo City, said, "there may be more problems in the quality of medicinal materials for retail investors, and the use of pesticides banned by the state cannot be excluded." Safety detection is an important part of the quality control of traditional Chinese medicine, but in the detection of pesticide residues and heavy metals, enterprises are facing the problem of inconsistent standards Some leaders of Chinese medicine enterprises believe that there is no unified view on what kind of medicinal materials are qualified The so-called qualified, not only refers to pesticide residues and heavy metal residues not exceeding the standard, but also has the efficacy At the end of 2012, the Hong Kong Health Department published the fifth issue of Hong Kong Standard for Chinese herbal medicines, which covers the safety and quality reference standards of 42 commonly used Chinese herbal medicines, and has made detailed provisions on the determination methods of heavy metal content, pesticide residues and index components of the herbal medicines Experts believe that whether these standards are reasonable and operable remains to be discussed "China's pharmacopoeia 2012 is implemented in the Chinese herbal medicine market Compared with the actual situation, the pharmacological properties of some Chinese herbal medicines are more difficult to grasp Chinese herbal medicines are the quintessence of the country and pay attention to the pure pharmaceutical properties." Han Shikai, vice chairman of the Hebei appraisal committee of traditional Chinese medicine, said: "now the Western analytical chemistry standard is used for the detection of traditional Chinese medicine Traditional Chinese medicine is the conclusion of clinical curative effect Traditional Chinese medicine is the basis of modern Chinese medicine What we pay attention to is that the compatibility and dosage form correspond to each other But now, the research is to split the prescription and treat the traditional Chinese medicine as medicine The standard of traditional Chinese Medicine is applied to the western medicine test standard " With the change of disease spectrum and medical model, the rise of "return to nature" and "green" consumption, the status of traditional natural medicine and plant medicine has been improved day by day Based on this, foreign pharmaceutical scholars and manufacturers are committed to finding new drug clues from plant medicine, trying to open up new ways of drug development, especially in Germany, Japan, South Korea and other countries Japan accounts for 80% of the global Chinese medicine market, while South Korea accounts for 10%, while China only accounts for 5%, according to one source Not only the international market of traditional Chinese medicine is occupied, but also foreign traditional Chinese medicine has entered the Chinese market Li Zhenjiang, chairman and President of Shenwei Pharmaceutical Group, said, "according to incomplete statistics, imported traditional Chinese medicine has accounted for 1 / 3 of the domestic market." In fact, the vast majority of foreign traditional Chinese medicines are cheap purchased from China After deep processing abroad, they are made into patent medicines and sold back to China at a high price In terms of the price of Ginkgo biloba leaves, Germany imports a large number of cheap products from China every year, and the products produced are resold back to China at a price 10 times higher than the original value Experts said that the advantages of foreign traditional Chinese medicine, such as high scientific and technological content, sophisticated materials, simple and clear positioning, are the reasons for its rapid development Li Zhenjiang said: "the biggest dependence of foreign traditional Chinese medicine is the quality advantage, that is, the high level of quality standards and specifications, especially in some European countries, the botanical preparations are generally marked with standard extracts or effective ingredients, which also reflects the shortcomings of China's quality standards compared with the lack of standardization, standardization and poor reproducibility." Experts believe that foreign traditional Chinese medicine accounts for 1 / 3 of the market share of Chinese patent medicine in China, which will aggravate the crisis of traditional Chinese medicine resources and the international competition of R & D and utilization of traditional Chinese medicine resources Li Zhenjiang said that some enterprises in Japan, South Korea, Southeast Asia and Western Europe purchased APIs at low prices from China for local rough processing and shipped them back to China to refine and extract preparations at high prices This is not only a great impact on China's traditional Chinese medicine industry, but also a threat to the healthy development of China's economy Professor Zhang Guijun, vice president of China commodity society and doctoral supervisor of traditional Chinese medicine major of Beijing University of traditional Chinese medicine, believed that there should be correspondence between quality evaluation indexes and clinical efficacy, and quality standards should be established on the basis of effective components of traditional Chinese medicine This is the core of the clinical treatment standard of traditional Chinese medicine, and also the basis of establishing a comprehensive evaluation system of traditional Chinese medicine quality in line with the theory of traditional Chinese medicine "The instructions for the use of highly toxic pesticides generally specify the scope of application The agricultural department only guides farmers to use them correctly For some farmers who use them illegally, there are no relevant laws and regulations, and there is a lack of government level supervision." Some heads of traditional Chinese medicine enterprises said that to solve this problem, relevant departments need to formulate relevant laws and regulations and strengthen law enforcement At the same time, Chinese medicine enterprises should also increase investment in scientific and technological research and development, improve the scientific and technological content of Chinese medicine products, and constantly improve the quality of Chinese medicine products China now has hundreds of Chinese medicine research institutions, more than 2000 Chinese patent medicine production enterprises, and more than 4000 kinds of Chinese patent medicines can be produced However, there are few major breakthroughs in innovation and even fewer of them can be converted into real productivity In the 40 years since the advent of artemisinin, there has not been a second comparable achievement Li Zhenjiang believes that it is necessary to increase the investment in scientific research of traditional Chinese medicine, especially to increase the research on the material basis of traditional Chinese medicine, adopt new production mode and management mode, develop new products and improve product quality.